he agreed with arguments by plaintiffs who oppose abortion rights in ruling that the agency improperly used a process of accelerated approval that didn't fully assess the drug's risks and benefits.

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

UPDATE (April 14, 4:40 p.m.): As of April 14, the Supreme Court has issued a temporary stay on restrictions of the drug while the justices evaluate whether they will issue a formal stay, following ...

But, Kavanaugh wrote, "allowing doctors or other healthcare providers to challenge general safety regulations as ... the stability of the FDA drug approval process, which is based on the agency's ...

"Because plaintiffs do not prescribe or use mifepristone, plaintiffs are unregulated parties who seek to challenge FDA's regulation ... stability of the FDA drug approval process, which is based ...